Renaissance Technologies - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 16 filers reported holding AC IMMUNE SA in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AC IMMUNE SA
ValueSharesWeighting
Q3 2023$1,212
-1.9%
425,179
+1.7%
0.00%0.0%
Q2 2023$1,235
+28.4%
417,979
+1.7%
0.00%
+100.0%
Q1 2023$962
+16.5%
411,079
+1.6%
0.00%0.0%
Q4 2022$826
-99.9%
404,679
-6.9%
0.00%
-50.0%
Q3 2022$1,374,000
-19.8%
434,879
-8.4%
0.00%0.0%
Q2 2022$1,713,000
-5.4%
474,590
+4.9%
0.00%0.0%
Q1 2022$1,810,000
-17.3%
452,490
+2.3%
0.00%
-33.3%
Q4 2021$2,189,000
-23.2%
442,190
+4.1%
0.00%
-25.0%
Q3 2021$2,850,000
-15.7%
424,690
-0.4%
0.00%0.0%
Q2 2021$3,380,000
+4.2%
426,190
-0.0%
0.00%0.0%
Q1 2021$3,244,000
+8.5%
426,290
-26.3%
0.00%
+33.3%
Q4 2020$2,991,000
-5.7%
578,560
-11.0%
0.00%0.0%
Q3 2020$3,173,000
-40.0%
650,211
-17.3%
0.00%
-40.0%
Q2 2020$5,290,000
+13.0%
786,011
+16.0%
0.01%0.0%
Q1 2020$4,680,000
+12.7%
677,311
+39.0%
0.01%
+66.7%
Q4 2019$4,153,000
+120.7%
487,402
+28.2%
0.00%
+50.0%
Q3 2019$1,882,000
+36.7%
380,102
+53.2%
0.00%
+100.0%
Q2 2019$1,377,000
+23.8%
248,039
+12.6%
0.00%0.0%
Q1 2019$1,112,000
+68.2%
220,250
+215.1%
0.00%0.0%
Q4 2018$661,000
+58.1%
69,900
+33.7%
0.00%
Q3 2018$418,000
-59.5%
52,300
-48.8%
0.00%
-100.0%
Q2 2018$1,032,000
+25.5%
102,105
+28.4%
0.00%0.0%
Q1 2018$822,000
+474.8%
79,525
+610.0%
0.00%
Q4 2017$143,000
-19.2%
11,200
-44.3%
0.00%
Q2 2017$177,00020,1000.00%
Other shareholders
AC IMMUNE SA shareholders Q2 2018
NameSharesValueWeighting ↓
Duquesne Family Office 1,500,000$24,705,0002.18%
Monashee Investment Management LLC 275,000$4,529,0001.59%
SPHERA FUNDS MANAGEMENT LTD. 79,800$1,314,0000.21%
Hillhouse Capital Management 550,000$9,059,0000.18%
Temasek Holdings (Private) Ltd 1,337,500$22,029,0000.18%
PointState Capital LP 425,000$7,000,0000.07%
Artal Group S.A. 150,000$2,471,0000.05%
HIGHLAND CAPITAL MANAGEMENT LP 87,900$1,448,0000.04%
Schonfeld Strategic Advisors LLC 14,779$243,0000.04%
Point72 Hong Kong Ltd 4,000$66,0000.04%
View complete list of AC IMMUNE SA shareholders